Supplemental Table 1. Patient Characteristics: Open Label and Randomized Double Blind Phase I/II Trial
Published: 15 December 2023| Version 1 | DOI: 10.17632/xx9b9bkzy7.1
Contributor:
Guy GoldmanDescription
Supplemental Table 1. Patient Characteristics: Open Label and Randomized Double Blind Phase I/II Trial
Files
Categories
Breast Cancer
Funding
Lutris Pharma